Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v10-EN
Language French English
Date Updated 2021-11-03 2021-09-13
Drug Identification Number 02444623 02444623
Brand name STRENSIQ STRENSIQ
Common or Proper name ASFOTASE ALFA ASFOTASE ALFA
Company Name ALEXION PHARMA GMBH ALEXION PHARMA GMBH
Ingredients ASFOTASE ALFA ASFOTASE ALFA
Strength(s) 40MG 40MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size 2ML, 3ML 2ML, 3ML
ATC code A16AB A16AB
ATC description OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2021-03-01 2021-03-01
Actual start date
Estimated end date 2021-12-31
Actual end date 2021-10-28
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments 28mg/0.7mL (40mg/mL) presentation 28mg/0.7mL (40mg/mL) presentation
Health Canada comments